MCRB
Seres Therapeutics Inc

9,294
Loading...
Loading...
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
103

Frequently Asked Questions

What is Market Cap of Seres Therapeutics Inc?
What is the 52-week high for Seres Therapeutics Inc?
What is the 52-week low for Seres Therapeutics Inc?
What is Seres Therapeutics Inc stock price today?
What was Seres Therapeutics Inc stock price yesterday?
What is the PE ratio of Seres Therapeutics Inc?
What is the Price-to-Book ratio of Seres Therapeutics Inc?
What is the 50-day moving average of Seres Therapeutics Inc?
How many employess does Seres Therapeutics Inc has?

Latest MCRB News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.